Towards the Virtual Physiological Human

Biomed Town5-7 November 2006 Brussels, Belgium
This event aims to contribute to the strategic development of a common European approach to the human physiome. It will provide an opportunity for the Community at large to join in the discussions related to that strategy, and to influence the course that the development will ultimately take.

The event is organised by "STEP: a Strategy for The EuroPhysiome", a cordination action partially supported by the European Commission. It aims to provide a roadmap to the development of the Virtual Physiological Human, a methodological and technological framework that once established will enable the investigation of the human body as a single complex system.

STEP represents a collective European response to the individual actions by creating an integrated framework - EuroPhysiome - which, while remaining true to the overall physiome concept, can accelerate the progress of the European teams by avoiding redundancy, enhancing compatibility and identifying deliverables and time scales.

The STEP Consortium actively encourages a wide participation in the Internet-based debate started after STEP Conference 1, which took place in May 2006.

This debate should allow a draft Roadmap (the final version of which is to be published by the STEP project in March 2007) to be broadened and deepened and will identify particular issues that will need to be discussed in detail at Conference 2, attendance at which is open to all.

For further information, please visit:
STEP Conference #2

Most Popular Now

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...

AXREM and Highland Marketing Partner to …

AXREM represents member companies that collectively provide UK hospitals with most of their diagnostic medical imaging technology, and radiotherapy equipment. The association has seen substantial growth in recent years, with membership...